| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 44.8827 | 27 |
| GSM780708 | Untreated after 4 days (C2_1) | 44.6503 | 25 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.5122 | 25 |
| GSM780719 | Untreated after 4 days (C1_2) | 41.8332 | 12 |
| GSM780720 | Untreated after 4 days (C2_2) | 45.6619 | 30 |
| GSM780721 | Untreated after 4 days (C3_2) | 44.3439 | 24 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 39.7237 | 6 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 40.846 | 9 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 44.7406 | 26 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 48.856 | 44 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 35.7765 | 1 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 39.897 | 6 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 39.7237 | 6 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 42.7882 | 16 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.8557 | 40 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 40.3649 | 7 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 47.4314 | 39 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 46.3268 | 34 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.8776 | 26 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 44.7961 | 26 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 41.2055 | 10 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 40.7166 | 9 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 42.0569 | 13 |